Gastrointestinal Stromal Tumor With Multiple Primary Tyrosine Kinase Mutations-Clinicopathologic and Molecular Characterization

被引:4
|
作者
Wong, Newton A. C. S. [1 ]
Taniere, Philippe [2 ]
Walsh, Shaun [3 ]
Wallace, Andrew [4 ]
Nonaka, Daisuke [5 ]
Jones, Thomas [6 ]
Gonzalez, David [7 ]
机构
[1] Southmead Hosp, Dept Cellular Pathol, Pathol Sci Bldg,Southmead Rd, Bristol BS10 5NB, Avon, England
[2] Queen Elizabeth Hosp, Dept Cellular Pathol, Birmingham, W Midlands, England
[3] Ninewells Hosp & Med Sch, Dept Pathol, Dundee, Scotland
[4] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, Genom Diagnost Lab, Manchester, Lancs, England
[5] Christie Hosp, Dept Histopathol, Manchester, Lancs, England
[6] Royal Marsden NHS Fdn Trust, Ctr Mol Pathol, London, England
[7] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland
关键词
GIST; KIT; PDGFRA; mutation; genetic heterogeneity; next generation sequencing; PDGFRA MUTATIONS; IMATINIB; GIST; KIT;
D O I
10.1097/PAI.0000000000000660
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
A unique cohort of chemo-naive gastrointestinal stromal tumors (GISTs) with double-primary tyrosine kinase mutations was characterized particularly to determine whether coexistent mutations represent a single mutational event. Up to 2013, 4 UK centers reported 9 GISTs with 2 primary tyrosine kinase mutations. In each of 8 cases validated by next generation sequencing, both mutations were present in the same allele of the same exon (KIT exon 11 or 17, or PDGFRA exon 18). One case showed the second mutation only on some of the mutant alleles. Seven cases showed both mutations in all the reads, but in 2 cases, additional variants were found only in some reads. Clinicopathologic features of the 8 cases were similar to GISTs with single-primary mutations. When GIST genotyping rarely uncovers multiple tyrosine kinase variants in an exon, they occur in the same allele but are likely to represent separate mutational events and lack clinical significance.
引用
收藏
页码:461 / 465
页数:5
相关论文
共 50 条
  • [1] Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumor
    Mrinal M. Gounder
    Robert G. Maki
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 25 - 43
  • [2] Molecular basis for primary and secondary tyrosine kinase inhibitor resistance in gastrointestinal stromal tumor
    Gounder, Mrinal M.
    Maki, Robert G.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 : 25 - 43
  • [3] Mutations of receptor tyrosine kinase genes in gastrointestinal stromal tumors
    Hirota, Seiichi
    Shincho, Mayumi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A75 - A75
  • [4] Molecular characterization and pathogenesis of gastrointestinal stromal tumor
    Niinuma, Takeshi
    Suzuki, Hiromu
    Sugai, Tamotsu
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 3
  • [5] Molecular analysis for new kinase mutations in imatinib resistant gastrointestinal stromal tumor patients.
    Ling, K.
    Liu, C.
    Tsen, C.
    Hsieh, R.
    Huang, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 216S - 216S
  • [7] Selecting Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor with Secondary KIT Activation-Loop Domain Mutations
    Hsueh, Yuan-Shuo
    Lin, Chih-Lung
    Chiang, Nai-Jung
    Yen, Chueh-Chuan
    Li, Chien-Feng
    Shan, Yan-Shen
    Ko, Ching-Huai
    Shih, Neng-Yao
    Wang, Ling-Mei
    Chen, Ting-Shou
    Chen, Li-Tzong
    PLOS ONE, 2013, 8 (06):
  • [8] Molecular and Clinicopathologic Characterization of Gastrointestinal Stromal Tumors (GISTs) of Small Size
    Rossi, Sabrina
    Gasparotto, Daniela
    Toffolatti, Luisa
    Pastrello, Chiara
    Gallina, Giovanna
    Marzotto, Alessandra
    Sartor, Chiara
    Barbareschi, Mattia
    Cantaloni, Chiara
    Messerini, Luca
    Bearzi, Italo
    Arrigoni, Giannantonio
    Mazzoleni, Guido
    Fletcher, Jonathan A.
    Casali, Paolo G.
    Talamini, Renato
    Maestra, Roberta
    Dei Tos, Angelo Paolo
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (10) : 1480 - 1491
  • [9] Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor
    Heinrich, MC
    Corless, CL
    Demetri, GD
    Blanke, CD
    von Mehren, M
    Joensuu, H
    McGreevey, LS
    Chen, CJ
    Van den Abbeele, AD
    Druker, BJ
    Kiese, B
    Eisenberg, B
    Roberts, PJ
    Singer, S
    Fletcher, CDM
    Silberman, S
    Dimitrijevic, S
    Fletcher, JA
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 4342 - 4349
  • [10] Analysis of clinicopathologic features and gene mutations in gastrointestinal stromal tumor: a series of 58 patients
    Cheng, Hao
    Qiu, Tian
    Shi, Su-Sheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2021, 14 (12): : 1128 - 1137